| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2248 |
| Trial ID | NCT04162756 |
| Disease | Mantle Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TeCAR-Tus |
| Recruitment status | Approved For Marketing |
| Title | Study of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell Malignancies |
| Year | 2019 |
| Country | United States |
| Company sponsor | Kite, A Gilead Company |
| Other ID(s) | KT-US-472-0118 |
| Cohort 1 | |||||||
|
|||||||